BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF ...

AtriCure announced the successful first-in-human AFib treatments using its novel dual-energy surgical cardiac ablation platform.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today ...

Catheter ablation significantly reduces cardiovascular risks and mortality in patients with both atrial fibrillation and obstructive sleep apnea. The study involved over 18,000 patients, showing a ...

Obstructive sleep apnea is associated with increased atrial fibrillation recurrence after ablation in patients with paroxysmal atrial fibrillation.

HCA Healthcare UK has introduced Medtronic’s Affera mapping and ablation system at The Harley Street Clinic, becoming the first independent provider in the UK to use the technology for atrial ...

Pulse Biosciences has entered a research partnership with The University of Texas MD Anderson Cancer Center, US, to ...

A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.

Intracardiac echocardiography is noninferior to TEE for prevention of thromboembolic complications in patients receiving ablation for AF.

Irregular heartbeats can signal AFib. Early detection and appropriate treatments help manage it and protect long-term heart health.

Boston Scientific (NYSE: BSX) announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) ...

Intracardiac echocardiography (ICE) devices are advanced ultrasound tools used to capture detailed, real-time images of the ...